- Home
- TLSA vs MCHX Comparison
TLSA vs MCHX Comparison
Compare TLSA & MCHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSA
- MCHX
- Stock Information
- Founded
- TLSA 2013
- MCHX 2003
- Country
- TLSA United Kingdom
- MCHX United States
- Employees
- TLSA N/A
- MCHX N/A
- Industry
- TLSA Biotechnology: Pharmaceutical Preparations
- MCHX Business Services
- Sector
- TLSA Health Care
- MCHX Consumer Discretionary
- Exchange
- TLSA Nasdaq
- MCHX Nasdaq
- Market Cap
- TLSA 187.0M
- MCHX 84.3M
- IPO Year
- TLSA 2000
- MCHX 2004
- Fundamental
- Price
- TLSA $1.67
- MCHX $1.94
- Analyst Decision
- TLSA
- MCHX
- Analyst Count
- TLSA 0
- MCHX 0
- Target Price
- TLSA N/A
- MCHX N/A
- AVG Volume (30 Days)
- TLSA 334.2K
- MCHX 15.5K
- Earning Date
- TLSA 05-06-2025
- MCHX 10-30-2025
- Dividend Yield
- TLSA N/A
- MCHX N/A
- EPS Growth
- TLSA N/A
- MCHX N/A
- EPS
- TLSA N/A
- MCHX N/A
- Revenue
- TLSA N/A
- MCHX $47,534,000.00
- Revenue This Year
- TLSA N/A
- MCHX N/A
- Revenue Next Year
- TLSA N/A
- MCHX $7.56
- P/E Ratio
- TLSA N/A
- MCHX N/A
- Revenue Growth
- TLSA N/A
- MCHX N/A
- 52 Week Low
- TLSA $0.63
- MCHX $1.26
- 52 Week High
- TLSA $2.60
- MCHX $2.40
- Technical
- Relative Strength Index (RSI)
- TLSA 43.49
- MCHX 44.19
- Support Level
- TLSA $1.63
- MCHX $1.95
- Resistance Level
- TLSA $1.88
- MCHX $2.03
- Average True Range (ATR)
- TLSA 0.16
- MCHX 0.05
- MACD
- TLSA -0.01
- MCHX -0.00
- Stochastic Oscillator
- TLSA 32.65
- MCHX 35.25
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
About MCHX Marchex Inc. Class B
Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business. It delivers data insights and incorporates artificial intelligence (AI)-powered functionality that drives insights and solutions to help companies find, engage, and support their customers across voice and text-based communication channels. The group enables sales and marketing teams to deliver the buying experiences that today's customers expect. The company generates the majority of its revenues from core analytics and solutions services. The company operates in the United States, Canada, and other countries.